NL-OMON51551招募中不适用
Early prediction of treatment response in children with Inflammatory Bowel Disease with Intestinal Ultrasound - RAINBOW-3
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 64（—）
入选标准
- •Newly onset IBD or flare IBD
- •Starting new remission induction therapy
排除标准
- •No visible abnormalities on baseline IUS
- •Infectious gastroenteritis
- •Acute severe ulcerative colitis
- •Surgery as remission induction therapy
- •Previous intestinal surgery
研究者
相似试验
已完成
不适用
Prediction of medication response in children with ADHD: EEG differences between responders and non-responders to methylphenidate.ADHD, methylphenidate response, EEG, DNA, CANTAB, spatial span, spatial working memory, stop-task, CPT, theta/beta ratioNL-OMON26488trecht Institute for Pharmaceutical Sciences, Utrecht University50
已完成
不适用
Prediction of medication response in children with Attention Deficit Hyperactivity Disorder (ADHD): Electroencephalogram (EEG) differences between responders and non-responders to methylphenidateMedication response in children with Attention Deficit Hyperactivity Disorder (ADHD)Mental and Behavioural DisordersHyperkinetic disordersISRCTN32841168trecht Institute for Pharmaceutical Sciences (The Netherlands)50
已完成
不适用
Assessing effectiveness and safety of two medications :nasal ketamine and oral promethazine as premedication in pediatric patients undergoing routine operationsCTRI/2016/03/006704St Stephens Hospital Delhi
招募中
不适用
Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosisDRKS00010936Klinik und Poliklinik für Psychiatrie und Psychotherapie,LVR-Klinikum Düsseldorf / Kliniken der Heinrich Heine Universität Düsseldorf600
进行中（未招募）
1 期
Traitement précoce de patients pédiatriques présentant un syndrome hémolytique et urémique typique par l’anticorps monoclonal anti-C5 eculizumab : essai thérapeutique prospectif randomisé contrôlé contre placebo de phase IIIHemolytic and uremic syndromeMedDRA version: 17.0 Level: LLT Classification code 10042814 Term: Syndrome hemolytic uremic System Organ Class: 100000004851EUCTR2014-001169-28-FRCentre Hospitalier de Toulouse100